ArticleInternational dental journal2026
Melatonin Rescues Enamel Defects Induced by Maternal Circadian Disruption via Targeting the BMAL1-JNK3 Axis.
Article in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
aimsDevelopmental defects of enamel (DDE) are highly prevalent, yet effective preventive measures remain elusive. The process of amelogenesis exhibits intrinsic circadian rhythmicity. While the photoperiod-regulated hormone melatonin is a recognized modulator of bone formation, its potential role in coordinating the circadian aspects of enamel biomineralization remains incompletely understood. This study aimed to decipher the impact of aberrant photoperiods on enamel development and to identify melatonin's regulatory targets.
methodsWe assessed the impact of maternal circadian disruption on offspring enamel mineralization using 3D X-ray microscopy (3DXRM), ATR-FTIR, SEM, Western blot, and qRT-PCR. Plasma melatonin concentration was measured by ELISA. Melatonin was administered to pregnant mice under circadian disruption to investigate its effects on enamel mineralization in their offspring. To investigate the molecular mechanisms downstream of BMAL1, we performed Bmal1 knockdown in ameloblast-lineage cells (ALCs) and used RNA sequencing and siRNA transfection.
resultsCircadian disruption impaired enamel mineralization (reduced thickness/density, increased CO₃²⁻/PO₄³⁻ ratio, rough surface with disorganized prisms), which was partially rescued by melatonin. Bmal1 knockdown in ALCs disrupted mitochondrial respiration, increased JNK3 phosphorylation, and reduced mineralization; melatonin restored mitochondrial function and suppressed JNK3 overactivation.
conclusionMechanistically, melatonin inhibits JNK3 phosphorylation to restore enamel mineralization. Bmal1 knockdown impairs the mitochondrial respiratory electron transport chain, while melatonin restores its function, thereby suppressing JNK3 overactivation and ultimately promoting mineralization. CLINICAL RELEVANCE: The BMAL1-JNK3 axis is a therapeutic target for enamel mineralization, providing a novel theoretical basis for perinatal circadian regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.